Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: a prospective cohort study
Journal of Neurology · 2025
DOI: 10.1007/s00415-024-12784-5 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Neurology, 2025. Verfasst von Min Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurobiology and Geriatrics, Xuanwu Hospital Capital Medical University, Beijing Institute of Geriatrics, 45 Changchun Stree…. Hauptthemen laut MEDLINE: Multiple System Atrophy, Neurofilament Proteins, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: the National Key R&D Program of China, Key Realm R&D Program of Guangdong Province, Beijing Traditional Chinese Medicine Technology Development Fund Project.
Abstract (Originalsprache)
BACKGROUND: Neurofilament light chain (NFL) in blood has been identified as a valuable biomarker in multiple system atrophy (MSA), but data regarding its utility in the early diagnosis and prognosis of MSA remain limited. OBJECTIVE: To investigate serum NFL's diagnostic and prognostic value in patients with MSA in a prospective clinical cohort. METHODS: Two hundred twenty-eight participants were enrolled, including ninety-eight with MSA, seventeen with uncertain MSA at inclusion, fifty-nine with Parkinson's disease (PD), and fifty-four healthy controls (HCs). Patients with MSA and uncertain diagnoses were followed up. Serum NFL levels were measured with electrochemiluminescence immunoassay at baseline. RESULTS: Patients with MSA and uncertain diagnoses underwent repeated clinical assessments with a median follow-up period of 1.43 years. The final diagnoses included 102 MSA, 62 PD, and 54 HCs. Serum NFL levels were significantly higher in MSA and PD than in HCs. Serum NFL levels, with cutoff values of 223.5 and 218.0 pg/mL, could discriminate between patients with MSA and PD (AUC = 0.930) in the early disease stages, and between MSA-parkinsonism subtypes and PD (AUC = 0.878). Higher serum NFL levels were independently associated with a shorter median time to poor prognosis and death. In addition, reduced levodopa responsiveness was correlated with poor outcomes, and orthostatic hypotension (OH) was linked to a higher risk of death. CONCLUSION: Serum NFL levels can not only differentiate between MSA, MSA-P, and PD in the early stages of the disease but also serve as a reliable independent predictor of poor prognosis and survival time in MSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Neurobiology and Geriatrics, Xuanwu Hospital Capital Medical University, Beijing Institute of Geriatrics, 45 Changchun Street, Xicheng District, Beijing, 100053, China.
- Department of Neurology, Beijing Longfu Hospital, Beijing, China.
- Department of Neurobiology, Clinical Center for Parkinson's Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory for Parkinson's Disease, Xuanwu Hospital of Capital…
- School of Health Professions, Stony Brook University, Stony Brook, New York, USA.
- Department of Neurology, Neurobiology and Geriatrics, Xuanwu Hospital Capital Medical University, Beijing Institute of Geriatrics, 45 Changchun Street, Xicheng District, Beijing, 100053, China. wei.mao@ccmu.edu.cn.
- Department of Neurology, Neurobiology and Geriatrics, Xuanwu Hospital Capital Medical University, Beijing Institute of Geriatrics, 45 Changchun Street, Xicheng District, Beijing, 100053, China. pbchan@hotmail.com.
Förderung
- the National Key R&D Program of China
- Key Realm R&D Program of Guangdong Province
- Beijing Traditional Chinese Medicine Technology Development Fund Project
Zitieren
APA
Liu, M., Cai, Y., Pan, J., Wang, T., Li, Y., Yu, Q., Mao, W., & Chan, P. (2025). Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: a prospective cohort study. Journal of Neurology. https://doi.org/10.1007/s00415-024-12784-5
Vancouver
Liu M, Cai Y, Pan J, Wang T, Li Y, Yu Q, et al. Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: a prospective cohort study. Journal of Neurology. 2025. doi:10.1007/s00415-024-12784-5
BibTeX
@article{Liu2025,
author = {Liu, Min and Cai, Yanning and Pan, Jing and Wang, Ting and Li, Yuan and Yu, Qian and Mao, Wei and Chan, Piu},
title = {Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: a prospective cohort study},
journal = {Journal of Neurology},
year = {2025},
doi = {10.1007/s00415-024-12784-5}
}
EUVIMED